These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 32677920

  • 1. Validation of the T86I mutation in the gyrA gene as a highly reliable real time PCR target to detect Fluoroquinolone-resistant Campylobacter jejuni.
    Espinoza N, Rojas J, Pollett S, Meza R, Patiño L, Leiva M, Camiña M, Bernal M, Reynolds ND, Maves R, Tilley DH, Kasper M, Simons MP.
    BMC Infect Dis; 2020 Jul 16; 20(1):518. PubMed ID: 32677920
    [Abstract] [Full Text] [Related]

  • 2. Detection of gyrA mutation among clinical isolates of Campylobacter jejuni isolated in Egypt by MAMA-PCR.
    Said MM, El-Mohamady H, El-Beih FM, Rockabrand DM, Ismail TF, Monteville MR, Ahmed SF, Klena JD, Salama MS.
    J Infect Dev Ctries; 2010 Oct 04; 4(9):546-54. PubMed ID: 21045366
    [Abstract] [Full Text] [Related]

  • 3. Droplet Digital PCR-Based Detection and Quantification of GyrA Thr-86-Ile Mutation Based Fluoroquinolone-Resistant Campylobacter jejuni.
    Luo Y, Zhang W, Cheng Y, Lu Q, Guo Y, Wen G, Shao H, Cheng Z, Luo Q, Zhang T.
    Microbiol Spectr; 2022 Apr 27; 10(2):e0276921. PubMed ID: 35412390
    [Abstract] [Full Text] [Related]

  • 4. Development of Multiplex-Mismatch Amplification Mutation-PCR Assay for Simultaneous Detection of Campylobacter jejuni and Mutation in gyrA Gene Related to Fluoroquinolone Resistance.
    Cui M, Wu C, Zhang P, Wu C.
    Foodborne Pathog Dis; 2016 Nov 27; 13(11):642-645. PubMed ID: 27584716
    [Abstract] [Full Text] [Related]

  • 5. Patterns of quinolone susceptibility in Campylobacter jejuni associated with different gyrA mutations.
    McIver C, Hogan T, White P, Tapsall J.
    Pathology; 2004 Apr 27; 36(2):166-9. PubMed ID: 15203753
    [Abstract] [Full Text] [Related]

  • 6. Analysis of topoisomerase mutations in fluoroquinolone-resistant and -susceptible Campylobacter jejuni strains isolated in Senegal.
    Kinana AD, Cardinale E, Bahsoun I, Tall F, Sire JM, Garin B, Boye CS, Dromigny JA, Perrier-Gros-Claude JD.
    Int J Antimicrob Agents; 2007 Apr 27; 29(4):397-401. PubMed ID: 17224260
    [Abstract] [Full Text] [Related]

  • 7. Enhanced in vivo fitness of fluoroquinolone-resistant Campylobacter jejuni in the absence of antibiotic selection pressure.
    Luo N, Pereira S, Sahin O, Lin J, Huang S, Michel L, Zhang Q.
    Proc Natl Acad Sci U S A; 2005 Jan 18; 102(3):541-6. PubMed ID: 15634738
    [Abstract] [Full Text] [Related]

  • 8. Single or double mutational alterations of gyrA associated with fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli.
    Bachoual R, Ouabdesselam S, Mory F, Lascols C, Soussy CJ, Tankovic J.
    Microb Drug Resist; 2001 Jan 18; 7(3):257-61. PubMed ID: 11759087
    [Abstract] [Full Text] [Related]

  • 9. Lack of correlation between the 257C-to-T mutation in the gyrA gene and clinical severity of Campylobacter jejuni infection in a region of high incidence of ciprofloxacin resistance.
    Sonnevend Á, Kovács J, Pál T, Akawi N, Nagelkerke N, Schneider G.
    Scand J Infect Dis; 2011 Dec 18; 43(11-12):905-11. PubMed ID: 21905953
    [Abstract] [Full Text] [Related]

  • 10. [PCR-restriction fragment length polymorphism assay (PCR-RFLP) as an useful tool for detection of mutation in gyrA gene at 86-THR position associated with fluoroquinolone resistance in Campylobacter jejuni].
    Wardak S, Szych J, Cieślik A.
    Med Dosw Mikrobiol; 2005 Dec 18; 57(3):295-301. PubMed ID: 16494206
    [Abstract] [Full Text] [Related]

  • 11. Analysis of gyrA mutations in quinolone-resistant and -susceptible Campylobacter jejuni isolates from retail poultry and human clinical isolates by non-radioactive single-strand conformation polymorphism analysis and DNA sequencing.
    Beckmann L, Müller M, Luber P, Schrader C, Bartelt E, Klein G.
    J Appl Microbiol; 2004 Dec 18; 96(5):1040-7. PubMed ID: 15078520
    [Abstract] [Full Text] [Related]

  • 12. Incidence and mechanism of ciprofloxacin resistance in Campylobacter spp. isolated from commercial poultry flocks in the United Kingdom before, during, and after fluoroquinolone treatment.
    Griggs DJ, Johnson MM, Frost JA, Humphrey T, Jørgensen F, Piddock LJ.
    Antimicrob Agents Chemother; 2005 Feb 18; 49(2):699-707. PubMed ID: 15673754
    [Abstract] [Full Text] [Related]

  • 13. High level of ciprofloxacin resistance and its molecular background among Campylobacter jejuni strains isolated in the United Arab Emirates.
    Sonnevend Á, Rotimi VO, Kolodziejek J, Usmani A, Nowotny N, Pál T.
    J Med Microbiol; 2006 Nov 18; 55(Pt 11):1533-1538. PubMed ID: 17030913
    [Abstract] [Full Text] [Related]

  • 14. Antimicrobial susceptibility of clinical isolates of Campylobacter jejuni from New South Wales, Australia.
    Devi A, Mahony TJ, Wilkinson JM, Vanniasinkam T.
    J Glob Antimicrob Resist; 2019 Mar 18; 16():76-80. PubMed ID: 30267925
    [Abstract] [Full Text] [Related]

  • 15. Molecular Dynamics Simulations of Quinolone Resistance-Associated T86I and P104S Mutations in Campylobacter jejuni gyrA: Unraveling Structural Repercussions.
    Mehla K, Ramana J.
    Microb Drug Resist; 2018 Apr 18; 24(3):232-243. PubMed ID: 28759328
    [Abstract] [Full Text] [Related]

  • 16. WQ-3810, a fluoroquinolone with difluoropyridine derivative as the R1 group exerts high potency against quinolone-resistant Campylobacter jejuni.
    Koide K, Kim H, Whelan MVX, Belotindos LP, Tanomsridachchai W, Changkwanyeun R, Usui M, Ó Cróinín T, Thapa J, Nakajima C, Suzuki Y.
    Microbiol Spectr; 2024 Oct 03; 12(10):e0432223. PubMed ID: 39162520
    [Abstract] [Full Text] [Related]

  • 17. Fluoroquinolone resistance detection in Campylobacter coli and Campylobacter jejuni by Luminex xMAP technology.
    Barco L, Lettini AA, Dalla Pozza MC, Ramon E, Fasolato M, Ricci A.
    Foodborne Pathog Dis; 2010 Sep 03; 7(9):1039-45. PubMed ID: 20500084
    [Abstract] [Full Text] [Related]

  • 18. Antibiotic resistance of Campylobacter jejuni isolates recovered from humans with diarrhoea in Turkey.
    Kayman T, Abay S, Aydin F, Şahin O.
    J Med Microbiol; 2019 Feb 03; 68(2):136-142. PubMed ID: 30540246
    [Abstract] [Full Text] [Related]

  • 19. Molecular epidemiological analysis of human- and chicken-derived isolates of Campylobacter jejuni in Japan using next-generation sequencing.
    Ohishi T, Aoki K, Ishii Y, Usui M, Tamura Y, Kawanishi M, Ohnishi K, Tateda K.
    J Infect Chemother; 2017 Mar 03; 23(3):165-172. PubMed ID: 28087306
    [Abstract] [Full Text] [Related]

  • 20. In vivo selection of Campylobacter isolates with high levels of fluoroquinolone resistance associated with gyrA mutations and the function of the CmeABC efflux pump.
    Luo N, Sahin O, Lin J, Michel LO, Zhang Q.
    Antimicrob Agents Chemother; 2003 Jan 03; 47(1):390-4. PubMed ID: 12499221
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.